Zydus Cadila launches Ramelteon Tablets

24 Jul 2019

Zydus Cadila has launched Ramelteon Tablets (US RLD -Rozerem Tablets), 8 mg upon receiving the final approval from the US Food & Drug Administration (USFDA). Ramelteon is a sedative, also called a hypnotic. It works by affecting certain substances in the body that help regulate the ‘sleep-wake cycle’. Ramelteon is used to treat insomnia that is associated with having trouble falling asleep. The drug will be manufactured at the group's formulations manufacturing facility at SEZ, Ahmedabad.

The group now has 270 approvals and has so far filed over 360 ANDAs since the commencement of the filing process in FY 2003-04.

Zydus Cadila is an innovative, global pharmaceutical company that discovers, develops, manufactures and markets a broad range of healthcare therapies.

Related Cadila Healthcare Ltd. Links:

Cadila Healthcare Share Price

224.65 -5.60 (-2.43%) Nov 13, 18:51
1 Year Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 411.70
Lupin 730.00
Dr. Reddys Lab 2761.90
Piramal Enterprises 1810.30
Cadila Healthcare 224.65
View more..
Sensex vs Cadila Healthcare
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323
Research Analyst - INH000000719

Callback

8055769463

8055769463